We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $1.68B
1-Year Est. Return 373.57%
This Fund
S&P 500
This Quarter Est. Return
+13.41%
1 Year Est. Return
+373.57%
3 Year Est. Return
+2,009.68%
5 Year Est. Return
+1,118.82%
10 Year Est. Return
+17,700.84%
AUM
$144M
AUM Growth
-$27.9M
Cap. Flow
-$88.5M
Cap. Flow %
-61.31%
Top 10 Hldgs %
91.04%
Holding
68
New
13
Increased
10
Reduced
2
Closed
37

Top Buys

Rank Stock Value
1
NXH
Neighborhood Intelligence Inc
NXH
+$6.75M
2
OGEN icon
Oragenics
OGEN
+$2.61M
3
AGX icon
Argan
AGX
+$2.27M
4
TRNX
Taronis Technologies, Inc. Common Stock
TRNX
+$1.99M
5
TOON icon
Kartoon Studios
TOON
+$1.23M

Top Sells

Rank Stock Value
1
TLRY icon
Tilray
TLRY
+$99.4M
2
OTRK
Ontrak
OTRK
+$1.13M
3
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
+$987K
4
IRD
Opus Genetics
IRD
+$565K
5
VLRX
VALERITAS HOLDINGS INC
VLRX
+$563K

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.73%
2 Real Estate 6.75%
3 Consumer Discretionary 4.27%
4 Industrials 3.66%
5 Healthcare 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UXIN
51
CALL
Uxin Ltd
UXIN
$246M
– –
-769
Closed -$374K
CSCI
52
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-3,358
Closed -$987K
IRD
53
Opus Genetics
IRD
$485M
– –
-12,648
Closed -$565K
LUMO
54
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-31,362
Closed -$429K
NTBL
55
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-1,314
Closed -$45K
TCON
56
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-1,251
Closed -$158K
SCPX
57
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
-15
Closed -$413K
ONCT
58
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-1,894
Closed -$207K
INFI
59
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-293,427
Closed -$346K
DTEA
60
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
– –
-326,414
Closed -$385K
VIVE
61
DELISTED
VIVEVE MED INC
VIVE
– –
-250
Closed -$263K
RESN
62
DELISTED
Resonant Inc.
RESN
– –
-210,631
Closed -$280K
TRIL
63
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-174,174
Closed -$298K
FRAN
64
DELISTED
Francesca's Holdings Corporation
FRAN
– –
-25,492
Closed -$297K
TTPH
65
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-16,797
Closed -$380K
FOMX
66
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-79,061
Closed -$284K
VLRX
67
DELISTED
VALERITAS HOLDINGS INC
VLRX
– –
-86,481
Closed -$563K
ONCS
68
DELISTED
OncoSec Medical Incorporated
ONCS
– –
-2,925
Closed -$412K
1 2
3

Similar funds

MCM
Maple Capital Management Montpelier, Vermont $1.68B AUM 27.38% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Anson Funds Management's Q1 2019 Portfolio in Review

As of Q1 2019, Anson Funds Management held 68 positions worth $144M, down 16% from $172M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Anson Funds Management withdrew a net $88.5M in Q1 2019, closing 37 positions and reducing 2 holdings. Its most notable exit was Tilray, an estimated $99.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 32% a quarter earlier, followed by Real Estate and Consumer Discretionary.

Against the trend, Anson Funds Management opened a new position in Neighborhood Intelligence Inc worth $6.17M.

  • Anson Funds Management's largest Q1 2019 buy was Neighborhood Intelligence Inc: 493,880 shares worth $6.17M.
  • Anson Funds Management added most to Argan in Q1 2019, an estimated $2.27M increase.
  • Anson Funds Management's biggest Q1 2019 reduction was Invitation Homes, cutting an estimated $114K.
  • Anson Funds Management fully exited Tilray in Q1 2019, selling an estimated $99.4M.
  • Anson Funds Management's ten largest holdings make up 91% of its $144M portfolio in Q1 2019.
  • Anson Funds Management opened 13 new positions and closed 37 in Q1 2019.
  • Anson Funds Management's portfolio value fell 16% quarter-over-quarter to $144M.

Based on Anson Funds Management's 13F filing for Q1 2019, filed 15 May 2019.